Nxstage Medical (NXTM) Tops Q3 EPS by 4c

Nxstage Medical (NASDAQ: NXTM) reported Q3 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $92 million versus the consensus estimate of $89.82 million.

GUIDANCE:

Nxstage Medical sees FY2016 revenue of $360-365 million.

For earnings history and earnings-related data on Nxstage Medical (NXTM) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Tesla to launch Cybercab in Austin this month - report